These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 27771404)

  • 1. Impact of Intensive LDL Cholesterol Lowering on Coronary Artery Atherosclerosis Progression: A Serial CT Angiography Study.
    Shin S; Park HB; Chang HJ; Arsanjani R; Min JK; Kim YJ; Lee BK; Choi JH; Hong GR; Chung N
    JACC Cardiovasc Imaging; 2017 Apr; 10(4):437-446. PubMed ID: 27771404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in LDL is associated with decrease in non-calcified plaque volume on coronary CTA as measured by automated quantitative software.
    Tamarappoo B; Otaki Y; Doris M; Arnson Y; Gransar H; Hayes S; Friedman J; Thomson L; Wang F; Rozanski A; Slomka P; Dey D; Berman D
    J Cardiovasc Comput Tomogr; 2018; 12(5):385-390. PubMed ID: 29793847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of statin intervention on mild coronary plaque progression assessed by serial coronary CT angiography].
    Li ZN; Hou ZH; Liu K; Wang ZQ; Yin WH; Gao Y; Xu HY; Jiang SL; Lyu B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Jun; 44(6):508-12. PubMed ID: 27346264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross-sectional survey of coronary plaque composition in individuals on non-statin lipid lowering drug therapies and undergoing coronary computed tomography angiography.
    Al'Aref SJ; Su A; Gransar H; van Rosendael AR; Rizvi A; Berman DS; Callister TQ; DeLago A; Hadamitzky M; Hausleiter J; Al-Mallah MH; Budoff MJ; Kaufmann PA; Raff GL; Chinnaiyan K; Cademartiri F; Maffei E; Villines TC; Kim YJ; Leipsic J; Feuchtner G; Pontone G; Andreini D; Marques H; de Araújo Gonçalves P; Rubinshtein R; Achenbach S; Chang HJ; Chow BJW; Cury R; Lu Y; Bax JJ; Jones EC; Peña JM; Shaw LJ; Min JK; Lin FY
    J Cardiovasc Comput Tomogr; 2019; 13(2):99-104. PubMed ID: 30745132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed tomography angiography defined vulnerable plaque in a patient with low high-density lipoprotein cholesterol and subsequent myocardial infarction.
    Rached FH; Rocha VZ; Santos RD; Serrano CV; Caixeta A
    Coron Artery Dis; 2017 Dec; 28(8):712-714. PubMed ID: 28704240
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of long-term intensive cholesterol control on the plaque progression in elderly based on CTA cohort study.
    Sun T; Wang Y; Wang X; Hu W; Li A; Li S; Xu X; Cao R; Fan L; Cao F
    Eur Radiol; 2022 Jul; 32(7):4374-4383. PubMed ID: 35226154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of LDL-C status on the association between increased coronary artery calcium score and compositional plaque volume progression in statins-treated diabetic patients: evaluated using serial coronary CTAs.
    Shi R; Gao Y; Shen LL; Shi K; Wang J; Jiang L; Li Y; Yang ZG
    Cardiovasc Diabetol; 2022 Jun; 21(1):121. PubMed ID: 35773708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
    Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
    Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggravating effect of abnormal low-density protein cholesterol level on coronary atherosclerotic plaque in type 2 diabetes mellitus patients assessed by coronary computed tomography angiography.
    Jiang YN; Gao Y; Zhang YS; Min CY; Shen LT; Yan WF; Yang ZG; Shi R; Li Y
    Cardiovasc Diabetol; 2024 Jul; 23(1):234. PubMed ID: 38965584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond early LDL cholesterol lowering to prevent coronary atherosclerosis in familial hypercholesterolaemia.
    Ibrahim S; Reeskamp LF; de Goeij JN; Hovingh GK; Planken RN; Bax WA; Min JK; Earls JP; Knaapen P; Wiegman A; Stroes ESG; Nurmohamed NS
    Eur J Prev Cardiol; 2024 May; 31(7):892-900. PubMed ID: 38243822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim results.
    Budoff MJ; Muhlestein JB; Bhatt DL; Le Pa VT; May HT; Shaikh K; Shekar C; Kinninger A; Lakshmanan S; Roy SK; Tayek J; Nelson JR
    Cardiovasc Res; 2021 Mar; 117(4):1070-1077. PubMed ID: 32609331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of plaque progression detected by serial coronary computed tomography angiography.
    Ito H; Motoyama S; Sarai M; Kawai H; Harigaya H; Kan S; Kato S; Anno H; Takahashi H; Naruse H; Ishii J; Narula J; Ozaki Y
    Heart Vessels; 2014 Nov; 29(6):743-9. PubMed ID: 24113717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of daily glucose fluctuation on coronary plaque vulnerability in patients pre-treated with lipid-lowering therapy: a prospective observational study.
    Kuroda M; Shinke T; Sakaguchi K; Otake H; Takaya T; Hirota Y; Sugiyama D; Nakagawa M; Hariki H; Inoue T; Osue T; Taniguchi Y; Iwasaki M; Nishio R; Kinutani H; Konishi A; Hiranuma N; Takahashi H; Terashita D; Hirata KI
    JACC Cardiovasc Interv; 2015 May; 8(6):800-811. PubMed ID: 25999102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Statins on Coronary Atherosclerotic Plaques: The PARADIGM Study.
    Lee SE; Chang HJ; Sung JM; Park HB; Heo R; Rizvi A; Lin FY; Kumar A; Hadamitzky M; Kim YJ; Conte E; Andreini D; Pontone G; Budoff MJ; Gottlieb I; Lee BK; Chun EJ; Cademartiri F; Maffei E; Marques H; Leipsic JA; Shin S; Choi JH; Chinnaiyan K; Raff G; Virmani R; Samady H; Stone PH; Berman DS; Narula J; Shaw LJ; Bax JJ; Min JK
    JACC Cardiovasc Imaging; 2018 Oct; 11(10):1475-1484. PubMed ID: 29909109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy.
    Hong MK; Lee CW; Kim YH; Park DW; Lee SW; Park CB; Jang JS; Han KH; Cheong SS; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2006 Oct; 98(7):866-70. PubMed ID: 16996864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density lipoprotein cholesterol and the risk of obstructive coronary artery disease beyond low-density lipoprotein cholesterol in non-diabetic individuals.
    Kim YG; Cho YR; Park GM; Won KB; Ann SH; Yang DH; Kang JW; Lim TH; Kim HK; Choe J; Lee SW; Kim YH; Yang YJ; Kim SJ; Lee SG
    Eur J Prev Cardiol; 2020 May; 27(7):706-714. PubMed ID: 31023096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental prognostic value of quantitative plaque assessment in coronary CT angiography during 5 years of follow up.
    Nadjiri J; Hausleiter J; Jähnichen C; Will A; Hendrich E; Martinoff S; Hadamitzky M
    J Cardiovasc Comput Tomogr; 2016; 10(2):97-104. PubMed ID: 26837235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plaque volume and plaque risk profile in diabetic vs. non-diabetic patients undergoing lipid-lowering therapy: a study based on 3D intravascular ultrasound and virtual histology.
    Kovarnik T; Chen Z; Mintz GS; Wahle A; Bayerova K; Kral A; Chval M; Kopriva K; Lopez J; Sonka M; Linhart A
    Cardiovasc Diabetol; 2017 Dec; 16(1):156. PubMed ID: 29212544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
    Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    J Am Coll Cardiol; 2015 Aug; 66(5):495-507. PubMed ID: 26227186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.